Skip to main content
Medical information Clinical review pending

Infection Testing

Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test

The Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test helps understand the immune response to SARS-CoV-2 (COVID-19) by detecting the virus and measuring IL-6 levels, a marker of inflammation.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
The test requires multiple sample types: 5 mL serum (from 2 SST tubes), 2 mL plasma (from 1 Lavender Top tube), 3 mL whole blood (from 1 Lavender Top tube), 3 mL whole blood (from 1 Blue Top tube), and Nasopharyngeal/Oropharyngeal swabs in viral transport medium. Specific forms (Covid-19 Clinical Information Form and Coagulation Requisition Form) are required.
Results
Results are typically available within 2 days after sample collection. Confirm with the laboratory before booking.
Preparation
Overnight fasting is preferred. Patients should avoid taking Biotin supplements for at least 8 hours before sample collection. Ensure all required forms are completed.
Test priceKSh 32,760

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals experiencing symptoms suggestive of COVID-19.
  • ✓Patients with risk factors for severe COVID-19.
  • ✓Monitoring the inflammatory response in confirmed COVID-19 cases.
  • ✓Assessing potential complications associated with COVID-19.
  • ✓Evaluating patients with severe respiratory illness.
02

In plain language

What this test helps you understand

This test helps healthcare providers understand the severity of a COVID-19 infection by assessing the inflammatory response (IL-6 levels) and identifying potential complications like blood clotting (D-Dimer). It aids in monitoring patients and guiding treatment decisions.
The Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test is a diagnostic tool used to assess the body's response to SARS-CoV-2, the virus that causes COVID-19. This test detects the presence of the virus and measures the level of Interleukin-6 (IL-6), a cytokine involved in the inflammatory response. High levels of IL-6 can be linked to more severe COVID-19 cases, making this test valuable for guiding medical care.

This comprehensive panel evaluates several key indicators:

* SARS-CoV-2 Qualitative PCR: Detects the presence of the virus. * IL-6: Measures the level of this specific cytokine. * Complete Blood Count (CBC): Provides a general overview of blood cell counts. * D-Dimer: Helps assess the risk of blood clots. * Other markers like Troponin-I, Ferritin, and C-Reactive Protein (CRP) may also be included.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is preferred. Patients should avoid taking Biotin supplements for at least 8 hours before sample collection. Ensure all required forms are completed.
SampleThe test requires multiple sample types: 5 mL serum (from 2 SST tubes), 2 mL plasma (from 1 Lavender Top tube), 3 mL whole blood (from 1 Lavender Top tube), 3 mL whole blood (from 1 Blue Top tube), and Nasopharyngeal/Oropharyngeal swabs in viral transport medium. Specific forms (Covid-19 Clinical Information Form and Coagulation Requisition Form) are required.
MethodologyThe panel utilizes various laboratory techniques, including PCR for virus detection and immunoassays or other methods for measuring cytokine and protein levels. Specific methods may vary. Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test provides a snapshot of the patient's condition at the time of sampling. Results should be interpreted in conjunction with clinical symptoms and other diagnostic findings. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Interleukin-6 (IL-6) is a protein (cytokine) that signals the immune system. Elevated levels can indicate inflammation, which is often seen in severe COVID-19 cases.
While often used for symptomatic individuals, it can also be considered for those with risk factors or for monitoring disease progression as advised by a doctor.
This test requires blood samples (serum, plasma, whole blood) and swabs from the nose and throat. Specific collection instructions apply.
Results are generally available within 2 days of receiving the sample. Confirm with the laboratory before booking.
Yes, overnight fasting is preferred. You should also avoid Biotin supplements for at least 8 hours prior to collection.
We have branches in major cities across Kenya and offer home sample collection services. Contact us to book.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp